within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07B_ViralVaccines.J07BA01_EncephalitisTickBorneInactivatedWholeVirus;
model EncephalitisTickBorneInactivatedWholeVirus 
   extends Pharmacolibrary.Drugs.ATC.J.J07BA01;

  annotation(Documentation(
    info ="<html><body><p>Inactivated whole virus vaccine for immunization against tick-borne encephalitis (TBE), an infectious disease caused by the tick-borne encephalitis virus. The vaccine is used prophylactically in endemic areas and is approved for use in many European and Asian countries, particularly for people at risk of tick exposure.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters published for inactivated, whole virus tick-borne encephalitis vaccine; as a vaccine (biologic), absorption, distribution, and elimination follow principles typical of intramuscularly administered protein antigens in healthy adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end EncephalitisTickBorneInactivatedWholeVirus;
